Cell Signaling Technology

HELLS Antibody

#7998 · $320

100
Citing papers
4.9k
Combined citations
Supplier page Find this product

Research areas

Autophagy in Disease and Therapy8Alzheimer's disease research and treatments8Inflammasome and immune disorders8Estrogen and related hormone effects8interferon and immune responses6MicroRNA in disease regulation6Cancer, Hypoxia, and Metabolism5Cytokine Signaling Pathways and Interactions5

Papers citing this product

1
Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions
PLoS ONE·2014·253 cit.·DOI
2
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
Clinical Proteomics·2010·247 cit.·DOI
3
Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes
The American Journal of Human Genetics·2012·198 cit.·DOI
4
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature
Journal of Neuroscience·2014·187 cit.·DOI
5
Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
Carcinogenesis·2010·142 cit.·DOI
6
Mapping the H+ (V)-ATPase interactome: identification of proteins involved in trafficking, folding, assembly and phosphorylation
Scientific Reports·2015·142 cit.·DOI
7
Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment
American Journal of Physiology-Heart and Circulatory Physiology·2017·134 cit.·DOI
8
Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
Journal of Cell Science·2011·129 cit.·DOI
9
The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation
Proceedings of the National Academy of Sciences·2015·125 cit.·DOI
10
Activation of G protein‐coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy
British Journal of Pharmacology·2017·125 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.